Overview

Safety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose is to determine if single doses of PUL-042 inhalation solution are safe in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Pulmotect, Inc.
Treatments:
Pam2CSK4 acetate and ODN M362 combination
Pharmaceutical Solutions